Iradimed Corp. announced in December that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its MRidium 3860+ magnetic resonance imaging (MRI)-compatible IV infusion pump system, including its Dose Error Reduction System (DERS) software feature.

NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) for its accelerator method of producing the medical radioisotope molybdenum-99 (Mo-99). The addition brings the total funding for the new method, in development by subisidiary NorthStar Medical Radioisotopes, to $11.1 million.

January 17, 2017 — Carestream Health was awarded 43 new patents from the U.S. Patent and Trademark Office last year for innovation in radiography, cone beam computed tomography (CT) imaging, healthcare information technology (IT) and other areas. The company also received 52 additional patents in European and Asian countries last year.

New patents earned by the company’s scientists and engineers included:

ECRI Institute announced a new mergers and acquisitions service that empowers new hospital alliances to control their spending and plan for the future by eliminating waste and redundancy in medical-surgical supplies and capital medical equipment.

January 17, 2017 — Siemens Healthineers and Biogen have announced the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions.

For the third straight year, Radiologic Associates of Fredericksburg (RAF) has been recognized by Radiology Business Journal as one of the nation's 100 largest privately owned radiology practices. The journal announced its 2016 "Radiology 100" ranking in the October/November issue.

Insightec, a leader in MR-guided focused ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its Exablate Neuro system for the non-invasive treatment of essential tremor in patients who have not responded to medication.

Seno Medical Instruments, Inc. announced results from two analyses of the company's European MAESTRO post-market surveillance study. The two analyses were presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) in San Antonio.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now